NanoCellect Biomedical
Signal active
Organization
Contact Information
Overview
NanoCellect Biomedical develops and delivers microfluidic-based solutions that are affordable, compact, and easy to use. Its expanding portfolio of instruments and consumables enables biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.
About
Industries
Biotechnology, Health Care, Medical Device, Health Diagnostics
Founded
2009
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
NanoCellect Biomedical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Health Diagnostics sector. The company focuses on Biotechnology and has secured $3.8B in funding across 80 round(s). With a team of 51-100 employees, NanoCellect Biomedical is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - NanoCellect Biomedical, raised $1.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$47.0M
Details
3
NanoCellect Biomedical has raised a total of $47.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | 15.0M | ||
| 2021 | Late Stage Venture | 20.0M | ||
| 2017 | Early Stage Venture | 10.0M |
Investors
NanoCellect Biomedical is funded by 34 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| NanoCellect Biomedical | - | FUNDING ROUND - NanoCellect Biomedical | 10.0M |
| Illumina Ventures | - | FUNDING ROUND - Illumina Ventures | 10.0M |
| Anzu Partners | - | FUNDING ROUND - Anzu Partners | 10.0M |
| NanoCellect Biomedical | - | FUNDING ROUND - NanoCellect Biomedical | 10.0M |
Recent Activity
There is no recent news or activity for this profile.